SEPSECS anticorps (N-Term)
Aperçu rapide pour SEPSECS anticorps (N-Term) (ABIN633298)
Antigène
Voir toutes SEPSECS AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- SLA/LP antibody was raised against the N terminal of SLA/LP
-
Attributs du produit
- Rabbit polyclonal SLA/LP antibody raised against the N terminal of SLA/LP
-
Purification
- Affinity purified
-
Immunogène
- SLA/LP antibody was raised using the N terminal of SLA/LP corresponding to a region with amino acids MDSNNFLGNCGVGEREGRVASALVARRHYRFIHGIGRSGDISAVQPKAAG
-
-
-
-
Indications d'application
-
WB: 1 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
SLA/LP Blocking Peptide, (ABIN5616165), is also available for use as a blocking control in assays to test for specificity of this SLA/LP antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SLA/LP antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- SEPSECS (Sep (O-phosphoserine) tRNA:Sec (Selenocysteine) tRNA Synthase (SEPSECS))
-
Autre désignation
- SLA/LP
-
Classe de substances
- Antibody
-
Sujet
- SLA/LP converts O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) required for selenoprotein biosynthesis.
-
Poids moléculaire
- 49 kDa (MW of target protein)
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-